Ticker ANAB – AnaptysBio – sales, description, marketcap – Tickerday.com

ANAB

AnaptysBio

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 411.19M; Volume: 48.95K; AvgVol 3m: 213.59K; Beta: 0.77;

Cost estimate:

P/E: –; EPS: -2.99; EPS growth quarter/prev quarter: 10.90%;

EPS growth this year: -43.90%; EPS growth past 5 years: ;

EPS ttm: -2.99;

P/S: 24.69; P/B: 1.14; P/Cashflow: 1.18; P/FCF: ;

Sales: 18.00M; Sales growth quarter/prev quarter: ; Sales growth past 5 years: -12.80%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -18.90%; ROE – return on equity: -20.20%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.59%; Insider Transactions:0.00%;

Institutional Ownership: ; Institutional Transactions: -3.72%;

Data update: 07/10/2020.